• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患者中脓肿分枝杆菌感染的危险因素;病例对照研究。

Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study.

机构信息

University of Utrecht, Faculty of Medicine, Utrecht, The Netherlands.

出版信息

J Cyst Fibros. 2012 Jul;11(4):340-3. doi: 10.1016/j.jcf.2012.01.006. Epub 2012 Feb 18.

DOI:10.1016/j.jcf.2012.01.006
PMID:22342403
Abstract

Mycobacterium abscessus is a nontuberculous mycobacterium that is increasingly recognized as an opportunistic pathogen in cystic fibrosis (CF) patients. Factors that predispose CF patients to infection by this environmental bacterium remain unknown. In a case-control study of 22 CF patients with M. abscessus infection and 22 CF controls, we investigated risk factors for MAB infection as well as the positioning of MAB infection in relation to the other pathogens infecting CF patients. No clear risk factors were found; steroid treatment and CF related diabetes were equally common among cases and controls. M. abscessus disease affects CF patients of varying age, lung function and co-morbidities. Antimicrobial maintenance therapy did not prevent M. abscessus infection. A history of Stenotrophomonas maltophilia infection was significantly more frequent among cases than among controls and there may be a relation with Aspergillus fumigatus infection, or both may be signs of advanced lung damage that predisposes to MAB disease. The absence of clear risk factors and the omnipresence of MAB in the environment suggest that MAB infection in CF patients is a random event. Its symptoms and impact on lung function seem to warrant treatment.

摘要

脓肿分枝杆菌是一种非结核分枝杆菌,它作为一种机会性病原体,在囊性纤维化(CF)患者中越来越受到关注。但导致 CF 患者易受这种环境细菌感染的因素仍不清楚。在一项对 22 名患有脓肿分枝杆菌感染的 CF 患者和 22 名 CF 对照者的病例对照研究中,我们调查了 MAB 感染的危险因素,以及 MAB 感染在 CF 患者感染的其他病原体中的定位。未发现明确的危险因素;皮质类固醇治疗和 CF 相关糖尿病在病例和对照组中同样常见。脓肿分枝杆菌病影响 CF 患者的年龄、肺功能和合并症各异。抗菌维持治疗并不能预防脓肿分枝杆菌感染。与对照组相比,病例组中史氏假单胞菌感染的病史明显更为频繁,这可能与烟曲霉感染有关,或者两者都可能是导致 MAB 疾病的晚期肺损伤的迹象。由于不存在明确的危险因素,而且环境中普遍存在 MAB,因此 CF 患者的 MAB 感染似乎是一种随机事件。其症状和对肺功能的影响似乎需要治疗。

相似文献

1
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study.囊性纤维化患者中脓肿分枝杆菌感染的危险因素;病例对照研究。
J Cyst Fibros. 2012 Jul;11(4):340-3. doi: 10.1016/j.jcf.2012.01.006. Epub 2012 Feb 18.
2
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.与变应性支气管肺曲霉病及类固醇治疗相关的囊性纤维化中的非结核分枝杆菌
Eur Respir J. 2005 Feb;25(2):324-8. doi: 10.1183/09031936.05.00058604.
3
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.鸟分枝杆菌和脓肿分枝杆菌复合体针对不同的囊性纤维化患者亚群。
J Cyst Fibros. 2013 Jan;12(1):74-80. doi: 10.1016/j.jcf.2012.06.009. Epub 2012 Jul 31.
4
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.比较囊性纤维化患者感染的马萨里隆分枝杆菌和脓肿分枝杆菌。
J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.
5
Increasing nontuberculous mycobacteria infection in cystic fibrosis.囊性纤维化中非结核分枝杆菌感染的增加。
J Cyst Fibros. 2015 Jan;14(1):53-62. doi: 10.1016/j.jcf.2014.05.008. Epub 2014 Jun 7.
6
Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.肺移植治疗术前分枝杆菌脓肿呼吸感染的囊性纤维化患者的结局。
Clin Transplant. 2013 Jul-Aug;27(4):523-9. doi: 10.1111/ctr.12140. Epub 2013 May 26.
7
Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.烟曲霉暴露前预处理可加重分枝杆菌感染小鼠的病理学改变,并改善其对脓肿分枝杆菌肺部感染的控制。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00859-17. Print 2018 Mar.
8
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.吸入疗法、阿奇霉素和脓肿分枝杆菌在囊性纤维化患者中的应用。
Eur Respir J. 2013 May;41(5):1101-6. doi: 10.1183/09031936.00065612. Epub 2012 Aug 30.
9
Infection control strategies that successfully controlled an outbreak of Mycobacterium abscessus at a cystic fibrosis center.在一家囊性纤维化中心成功控制脓肿分枝杆菌暴发的感染控制策略。
Am J Infect Control. 2016 Feb;44(2):154-9. doi: 10.1016/j.ajic.2015.08.023. Epub 2015 Oct 9.
10
Pulmonary Mycobacterium abscessus: a canary in the cystic fibrosis coalmine.肺脓肿分枝杆菌:囊性纤维化煤矿中的金丝雀。
J Infect. 2012 Jun;64(6):609-12. doi: 10.1016/j.jinf.2012.02.010. Epub 2012 Feb 23.

引用本文的文献

1
[Patients with lung disease caused by non-tuberculous mycobacteria in Germany: a trans-sectoral patient-oriented care concept].[德国非结核分枝杆菌所致肺部疾病患者:以患者为导向的跨部门照护理念]
Pneumologie. 2022 Aug;76(8):534-546. doi: 10.1055/a-1855-0858. Epub 2022 Jul 25.
2
Glby, Encoded by , Is Required for Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity.Glby 由编码,是分枝杆菌生长所必需的,并且表现出轻微的β-内酰胺酶活性。
J Bacteriol. 2022 May 17;204(5):e0004622. doi: 10.1128/jb.00046-22. Epub 2022 Apr 5.
3
Severe Pulmonary s Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan.
在日本,克拉霉素和西他沙星联合治疗其他微生物合并感染所致的重症肺部病例效果良好。
Int Med Case Rep J. 2021 Jul 12;14:465-470. doi: 10.2147/IMCRJ.S321969. eCollection 2021.
4
THP-1 and Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds.THP-1 细胞和感染模型在抗脓肿分枝杆菌命中化合物的筛选和特性表征中的应用。
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.01601-19.
5
Aspergillus fumigatus Preexposure Worsens Pathology and Improves Control of Mycobacterium abscessus Pulmonary Infection in Mice.烟曲霉暴露前预处理可加重分枝杆菌感染小鼠的病理学改变,并改善其对脓肿分枝杆菌肺部感染的控制。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00859-17. Print 2018 Mar.
6
Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.评估用于检测囊性纤维化患者中快速生长分枝杆菌的各种培养基
J Clin Microbiol. 2016 Jul;54(7):1797-1803. doi: 10.1128/JCM.00471-16. Epub 2016 Apr 20.
7
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.美国囊性纤维化基金会和欧洲囊性纤维化协会关于囊性纤维化患者非结核分枝杆菌管理的共识建议。
Thorax. 2016 Jan;71 Suppl 1(Suppl 1):i1-22. doi: 10.1136/thoraxjnl-2015-207360.
8
Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.土耳其囊性纤维化患者中分枝杆菌的患病率及耐药性
Ann Clin Microbiol Antimicrob. 2014 Aug 13;13:28. doi: 10.1186/1476-0711-13-28.
9
Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.非结核分枝杆菌:囊性纤维化的流行变化及治疗挑战。
Curr Opin Pulm Med. 2013 Nov;19(6):662-9. doi: 10.1097/MCP.0b013e328365ab33.
10
Nontuberculous mycobacteria in respiratory samples from patients with pulmonary tuberculosis in the state of Rondônia, Brazil.巴西朗多尼亚州肺结核患者呼吸道样本中的非结核分枝杆菌。
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):457-62. doi: 10.1590/S0074-0276108042013010.